A Study of the Addition of Avastin (Bevacizumab) to Carboplatin and Paclitaxel Therapy in Patients With Ovarian Cancer
Clinical trial NCT01239732 · COMPLETED
Trial details
- NCT number
- NCT01239732
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-12-01
- Primary completion
- 2015-03-01
- Enrollment
- 1021
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.